Inhibrx Biosciences Inc

We track 1 ClinicalTrials.gov studies led by Inhibrx Biosciences Inc. The portfolio skews toward Phase 3 (1 trials).

1 clinical trials sponsored by Inhibrx Biosciences Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials by Inhibrx Biosciences Inc

A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First Line Treatment for Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Expressing PD-L1 (CPS ≥20) (HexAgon-HN)

NCT06295731 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Inhibrx Biosciences Inc sponsor?

Inhibrx Biosciences Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.

What conditions does Inhibrx Biosciences Inc research?

Inhibrx Biosciences Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Inhibrx Biosciences Inc recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More